Trinity Biotech plc

Trinity Biotech plc develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments. Its clinical laboratory offerings include tests and instruments for infectious diseases such as syphilis, herpes, SARS-CoV-2, Epstein-Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella, as well as in-vitro diagnostic measurement of haemoglobin A1c for diabetes monitoring and risk identification. The company also provides laboratory-testing services for autoimmune disorders including Sjögren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, and systemic sclerosis, and develops products in immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats. It serves public health authorities and clinical and reference laboratories through direct sales and independent distributors, and has collaboration agreements with a bioinformatics company for EpiCapture and with Echelon Data Centres for liquid cooling solutions. Incorporated in 1992, it is headquartered in Bray, Ireland.